Open Access Article
Jennifer Shyonga,
Jinliang Wanga,
Quoc-Dung Tran Huynhd,
Marina Fayzullinaa,
Bo Yuana,
Ching-Kuo Leecd,
Thomas Minehane,
Paul M. Seidler*a and
Clay C. C. Wang*ab
aDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089, USA. E-mail: clayw@usc.edu; pseidler@usc.edu
bDepartment of Chemistry, University of Southern California, Dornsife College of Letters, Arts, and Sciences, Los Angeles, California 90089, USA
cSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
dPhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
eDepartment of Chemistry and Biochemistry, California State University, Northridge, Northridge, California 91330, USA
First published on 23rd June 2026
Correction for ‘Discovery of penicillic acid as a chemical probe against tau aggregation in Alzheimer's disease’ by Jennifer Shyong et al., Chem. Sci., 2024, 15, 20467–20477, https://doi.org/10.1039/D4SC05469E.
Acknowledgements
We thank the donors and their families, without whom this work would not have been possible. We are grateful to Simulations Plus for providing a license for ADMET Predictor® through the University + program. We also thank the BrightFocus Foundation (A2023016S). TM acknowledges support from the National Science Foundation (CHE-2003261). Figures were created with https://www.biorender.com/.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |